Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001615219-19-000015
Filing Date
2019-04-24
Accepted
2019-04-24 16:14:44
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 flks20190424s-3.htm S-3 412044
2 EXHIBIT 4.4 flks20190424s-3ex44.htm EX-4.4 457392
3 EXHIBIT 4.6 flks20190424s-3ex46.htm EX-4.6 178013
4 EXHIBIT 4.7 flks20190424s-3ex47.htm EX-4.7 164066
5 EXHIBIT 4.8 flks20190424s-3ex48.htm EX-4.8 147840
6 EXHIBIT 5.1 flks20190424s-3ex51.htm EX-5.1 31547
7 EXHIBIT 23.1 flks20190424s-3ex231.htm EX-23.1 5514
8 cooleya03.jpg GRAPHIC 9853
9 flexpharma.jpg GRAPHIC 12743
10 flexpharmaa01.jpg GRAPHIC 12743
  Complete submission text file 0001615219-19-000015.txt   1441006
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231010 | Film No.: 19763994
SIC: 2834 Pharmaceutical Preparations